Algernon Pharmaceuticals Inc presenting at the Proactive One2One Virtual Forum – 9th August 2022

Algernon Pharmaceuticals Inc CEO, Christopher J. Moreau, presenting at the Proactive One2One Virtual Forum

Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets.

Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

© 2022 Stockmark.it The Latest StockMarket News and Interviews